NCT00603330View on ClinicalTrials.gov

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Graft-versus-host DiseasePoor Graft FunctionLow Donor T-cell Chimerism
Interventions
BIOLOGICAL

Mesenchymal stem cells

Mesenchymal Stem Cell infusion

Trial Locations (12)

1020

RECRUITING

Hôpital des enfants Reine Fabiola, Brussels

1090

RECRUITING

AZ VUB Jette, Brussels

1200

RECRUITING

Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Brussels

2060

RECRUITING

Hôpital Stuyvenberg, Antwerp

2650

RECRUITING

UZA, Edegem

3000

RECRUITING

AZ Gasthuisberg Leuven, Leuven

4000

RECRUITING

CHU Sart Tilman, Liège

5530

RECRUITING

Cliniques Universitaires Mont-Godinne, Yvoir

6200

NOT_YET_RECRUITING

University Hospital Maastricht, Maastricht

7100

RECRUITING

Hôpital de Jolimont, Haine-Saint-Paul

8000

RECRUITING

AZ St Jan, Bruges

9000

RECRUITING

UZ Gent, Ghent

All Listed Sponsors
collaborator

KU Leuven

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Ziekenhuis Netwerk Antwerpen (ZNA)

OTHER

collaborator

University Hospital, Antwerp

OTHER

collaborator

University Hospital, Ghent

OTHER

collaborator

AZ-VUB

OTHER

collaborator

AZ Sint-Jan AV

OTHER

collaborator

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

collaborator

University Hospital of Mont-Godinne

OTHER

collaborator

Jolimont Hospital Haine Saint Paul

UNKNOWN

collaborator

Queen Fabiola Children's University Hospital

OTHER

lead

University of Liege

OTHER